KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Short term Debt (2016 - 2026)

Pfizer has reported Short term Debt over the past 18 years, most recently at $3.9 billion for Q1 2026.

  • Quarterly Short term Debt fell 12.98% to $3.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 billion through Mar 2026, down 12.98% year-over-year, with the annual reading at $3.2 billion for FY2025, 54.59% down from the prior year.
  • Short term Debt was $3.9 billion for Q1 2026 at Pfizer, up from $3.2 billion in the prior quarter.
  • Over five years, Short term Debt peaked at $11.9 billion in Q2 2024 and troughed at $645.0 million in Q2 2022.
  • The 5-year median for Short term Debt is $4.3 billion (2025), against an average of $5.4 billion.
  • Year-over-year, Short term Debt crashed 85.18% in 2022 and then skyrocketed 549.3% in 2023.
  • A 5-year view of Short term Debt shows it stood at $2.9 billion in 2022, then soared by 251.44% to $10.4 billion in 2023, then tumbled by 32.89% to $6.9 billion in 2024, then tumbled by 54.59% to $3.2 billion in 2025, then rose by 23.34% to $3.9 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Short term Debt are $3.9 billion (Q1 2026), $3.2 billion (Q4 2025), and $4.3 billion (Q3 2025).